Esperion Therapeutics Inc Analyst and Investor Day Transcript
Hello. All right. Perfect. Thank you, everyone. If you can just take your seats, we're about to get started right now. So hi, everyone. I'm Alex Schwartz. I head Investor Relations here at Esperion, and welcome to our 2019 Investor and Analyst Day. I'm excited for what we have planned for you today.
First, you're going to be hearing some new stuff from us. You're going to meet our highly experienced and successful commercial leadership team. You're going to be learning about launch plans for bempedoic acid and the bempedoic acid combination tablet in the United States. And finally, you're going to get the chance to ask a lot of questions.
Before we get into today's events, I just want to take a moment to point out this slide. The presentation we're making and the accompanying statements are forward-looking in nature. They are covered under the Safe Harbor Provisions Act.
Now I'd like to draw your attention to today's agenda. Throughout today, you'll be hearing from members of our Lipid Management Team
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |